ImmunityBio, Inc. Quarterly Operating Margin in % from Q4 2014 to Q1 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
ImmunityBio, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2014 to Q1 2024.
  • ImmunityBio, Inc. Operating Margin for the quarter ending March 31, 2024 was -115K %, a 82.9% decline year-over-year.
  • ImmunityBio, Inc. annual Operating Margin for 2023 was -58.2K %, a 60.2% increase from 2022.
  • ImmunityBio, Inc. annual Operating Margin for 2022 was -146K %, a 314% decline from 2021.
  • ImmunityBio, Inc. annual Operating Margin for 2021 was -35.4K %, a 3.14% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -115K -51.9K -82.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -58.2K +88.1K +60.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -65.1K -3.01K -4.84% Jul 1, 2023 Sep 30, 2023
Q2 2023 -62.9K +3.17K +4.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -62.6K -20.6K -49% Jan 1, 2023 Mar 31, 2023
Q4 2022 -146K -111K -314% Oct 1, 2022 Dec 31, 2022
Q3 2022 -62.1K -12.2K -24.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -66.1K -24.7K -59.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -42K -10.7K -34.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -35.4K -11.5K -48.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -49.9K -27.6K -124% Jul 1, 2021 Sep 30, 2021
Q2 2021 -41.4K -22.1K -115% Apr 1, 2021 Jun 30, 2021
Q1 2021 -31.3K +11.1K +26.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -23.9K +134K +84.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -22.3K +147K +86.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -19.3K +110K +85.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -42.5K +146K +77.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -158K +51.6K +24.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -169K +34.7K +17% Jul 1, 2019 Sep 30, 2019
Q2 2019 -129K +238K +64.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -188K +73.2K +28% Jan 1, 2019 Mar 31, 2019
Q4 2018 -209K +10.9K +4.96% Oct 1, 2018 Dec 31, 2018
Q3 2018 -204K +6.39K +3.04% Jul 1, 2018 Sep 30, 2018
Q2 2018 -367K -157K -74.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -261K -19.9K -8.22% Jan 1, 2018 Mar 31, 2018
Q4 2017 -220K +62.7K +22.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 -210K +76.9K +26.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -210K +122K +36.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -242K -46.1K -23.6% Jan 1, 2017 Mar 31, 2017
Q4 2016 -283K -182K -180% Oct 1, 2016 Dec 31, 2016
Q3 2016 -287K -221K -333% Jul 1, 2016 Sep 30, 2016
Q2 2016 -332K -295K -785% Apr 1, 2016 Jun 30, 2016
Q1 2016 -195K -188K -2419% Jan 1, 2016 Mar 31, 2016
Q4 2015 -101K -100K -11538% Oct 1, 2015 Dec 31, 2015
Q3 2015 -66.3K Jul 1, 2015 Sep 30, 2015
Q2 2015 -37.6K Apr 1, 2015 Jun 30, 2015
Q1 2015 -7.76K Jan 1, 2015 Mar 31, 2015
Q4 2014 -870 Oct 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.